Neamine inhibits growth of pancreatic cancer cells In Vitro and In Vivo

Abstract

Neamine, a non-toxic derivative of neomycin, has recently been shown to have antitumor activities in various types of cancers. However, its effect on pancreatic cancer is still unknown. The study aimed to investigate its antitumor activity on pancreatic cancer and the underlying mechanisms. MTT assay was used to observe the effect of neamine on angiogenin (ANG)-induced AsPC-1 cell proliferation. Tissue microassay and immunofluorescence staining were used to detect the expression of ANG and its nuclear translocation, respectively. Tumor xenografts were established by subcutaneous inoculation of AsPC-1 pancreatic cancer cells into the right flanks of nude mice, and neamine was injected subcutaneously. Immunohistochemistry was done to observe the expression of ANG, CD31 and Ki-67 in tumor xenografts. It was found that neamine blocked the nuclear translocation of ANG effectively and inhibited ANG-induced AsPC-1 cell proliferation in a dose-dependent manner. Neamine had anti-tumor effects on AsPC-1 xenograft models. Consistently, neamine reduced the expression levels of ANG, Ki-67 and CD31 in tumor xenografts. It was concluded that neamine may be a promising agent for treatment of pancreatic cancer.

Keywords

neamine / angiogenin / pancreatic cancer / cell proliferation / angiogenesis

References

[1] VincentA, HermanJ, SchulickR, et al. . Pancreatic cancer. Lancet, 2011, 378(9791): 607-620 PMCID: 3062508 PMID: 21620466

[2] SiegelR, MaJ, ZouZ, et al. . Cancer statistics. CA cancer J Clin, 2014, 64(1): 9-29 PMID: 24399786

[3] LiuSX, XiaZS, ZhongYQ. Genetic therapy in pancreatic cancer. World J Gastroenterol, 2014, 20(37): 13343-13368 PMCID: 4188890 PMID: 25309069

[4] BurrisH, StornioloA. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer, 1997, 33: S18-S22 PMID: 9166095

[5] SeoY, BabaH, FukudaT, et al. . High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer, 2000, 88(10): 2239-2245 PMID: 10820344

[6] FujimotoK, HosotaniR, WadaM, et al. . Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer, 1998, 34(9): 1439-1447 PMID: 9849429

[7] WangH, ChenQ. Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas. Chin Ger J Clin Oncol, 2005, 22(2): 121-123

[8] FettJW, StrydomDJ, LobbRR, et al. . Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 1985, 24(20): 5480-5486 PMID: 4074709

[9] LiR, RiordanJF, HuG. Nuclear translocation of human angiogenin in cultured human umbilical artery endothelial cells is microtubule and lysosome independent. Biochem Biophys Res Commun, 1997, 238(238): 305-312 PMID: 9299500

[10] MoroianuJ, RiordanJF. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA, 1994, 91(5): 1677-1681 PMCID: 43226 PMID: 8127865

[11] KishimotoK, LiuS, TsujiT, et al. . Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene, 2005, 24(3): 445-456 PMID: 15558023

[12] BotteroV, SadagopanS, JohnsonKE, et al. . Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation. J Virol, 2013, 87(21): 11806-11820 PMCID: 3807355 PMID: 23986578

[13] ShimoyamaS, GansaugeF, GansaugeS, et al. . Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res, 1996, 56(12): 2703-2706 PMID: 8665497

[14] OlsonKA, FettJW, FrenchTC, et al. . Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci USA, 1995, 92(2): 442-446 PMCID: 42756 PMID: 7831307

[15] OlsonKA, FrenchTC, ValleeBL, et al. . A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res, 1994, 54(17): 4576-4579 PMID: 8062244

[16] OlsonKA, ByersHR, KeyME, et al. . Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res, 2001, 7(11): 3598-3605 PMID: 11705882

[17] SadagopanS, Sharma-WaliaN, VeettilMV, et al. . Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J Virol, 2009, 83(7): 3342-3364 PMCID: 2655544 PMID: 19158252

[18] HuGF. Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci USA, 1998, 95: 9791-9795 PMCID: 21415 PMID: 9707554

[19] WilliamsP, BennettD, GleasonC, et al. . Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother, 1987, 31(4): 570-574 PMCID: 174778 PMID: 3606061

[20] ZhaoJ, WangYC, YangLY, et al. . Neamine inhibits cell proliferation, migration, and invasion in H7402 human hepatoma cells. Saudi Med J, 2010, 31(12): 1309-1314 PMID: 21135992

[21] KishimotoK, YoshidaS, IbaragiS, et al. . Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation. Anticancer Res, 2014, 34(5): 2113-2121 PMID: 24778013

[22] YuanY, WangF, LiuXH, et al. . Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer, 2009, 66(1): 28-36 PMID: 19423182

[23] HirukawaS, OlsonKA, TsujiT, et al. . Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice. Clin Cancer Res, 2005, 11(24): 8745-8752 PMID: 16361562

[24] IbaragiS, YoshiokaN, LiS, et al. . Neamine inhibits prostate cancer growth by suppressing angiogeninmediated rRNA transcription. Clin Cancer Res, 2009, 15(6): 1981-1988 PMCID: 2670466 PMID: 19276260

[25] YapingL, XiaoyanZ, SonglinA, et al. . Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo. Cancer Chemother Pharmacol, 2015, 75(3): 465-474

[26] LiuYP, HuGF, WuYX. Neamine is preferential as an anti-prostate cancer reagent by inhibiting cell proliferation and angiogenesis with lower toxicity than cis-platinum. Oncol Lett, 2015, 10(1): 137-142 PMCID: 4487084 PMID: 26170989

[27] DengSR, LiJ, ZhangZQ, et al. . DS147 improves pregnancy in mice with embryo implantation dysfunction induced by controlled ovarian stimulation. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(4): 573-580 PMID: 23904380

[28] SaifMW. Anti-angiogenesis therapy in pancreatic carcinoma. Jop, 2006, 7(2): 163-173 PMID: 16525200

[29] TsujiT, SunY, KishimotoK, et al. . Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res, 2005, 65(4): 1352-1360 PMID: 15735021

[30] SathishS, MohananVV, NitikaP, et al. . Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. J Virol, 2011, 85(6): 2666-2685